Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11878961
Next generation FKBP52 targeting drugs for the treatment of prostate and breast cancer
granted -
US 11873291
Quinoline cGAS antagonist compounds
granted -
US 11872312
Neuroprotective liposome compositions and methods for treatment of stroke
granted -
US 11872092
Methods for surgical guidance in breast cancer surgery and lymph node dissection using two or more implantation devices comprising a capsule and a population of ultrasound-switchable fluorophores incorporated in the capsule
granted -
US 11865157
Compositions and methods of targeting cancer stem cells
granted -
US 11858956
6-aza-nucleoside prodrugs as antiviral agents for treating virus infections
granted -
US 11858884
Compositions and methods for modulating gene or gene product in cells
granted -
US 11857701
Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
granted -
US 11851464
Methods and compositions related to recombinant NEIL2
granted -
US 11844805
Formulations of testosterone and methods of treatment therewith
granted -
US 11839650
Universal influenza vaccine targeting virus/host recognition
granted -
US 11840536
Heterocyclic inhibitors of PTPN11
granted -
US 11839615
Compounds and methods for treating addiction and related disorders
granted -
US 11840690
Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAs targeting the expanded hexanucleotide repeat
granted -
US 11834640
Device and uses thereof for treating diabetes
granted -
US 11826332
Antimicrobial compositions and uses thereof
granted -
US 11826422
Methods and compositions for adaptive immune modulation
granted -
US 11807853
Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune diseases and cancer
granted -
US 11801218
Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
granted -
US 11801295
Immunogenic compositions and uses thereof
granted -
US 11802272
Enrich and amplify highly potent human mesenchymal stem cells from elderly cell populations
granted -
US 11795457
Compositions and methods for treatment of Friedreich's Ataxia
granted -
US 11786500
Glutaminase inhibitor therapy
granted -
US 11786582
Human application of engineered chimeric antigen receptor (CAR) T-cells
granted